Article Details

Federal Circuit Affirms Obviousness of Rifaximin Polymorph Patents and Denial of Motion to ...

Retrieved on: 2024-04-26 15:29:34

Tags for this article:

Click the tags to see associated articles and topics

Federal Circuit Affirms Obviousness of Rifaximin Polymorph Patents and Denial of Motion to .... View article details on hiswai:

Excerpt

In a precedential opinion issued on April 11, 2024 in Salix Pharmaceuticals, Ltd. v. Norwich Pharmaceuticals Inc., Nos. 22-2153, 23-1952, the U.S. ...

Article found on: www.jdsupra.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up